EUA
SARS-CoV-2 Test Kit (Real-time PCR)
FDA Emergency Use Authorization · Xiamen Zeesan Biotech Co., Ltd. · Feb 27, 2023
Key facts
| Product | SARS-CoV-2 Test Kit (Real-time PCR) |
|---|---|
| Company | Xiamen Zeesan Biotech Co., Ltd. |
| Product type | Real-time RT-PCR, Multiple Targets |
| Date | Feb 27, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: